402 related articles for article (PubMed ID: 10545680)
1. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
Hiatt MD
Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
3. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
[TBL] [Abstract][Full Text] [Related]
6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
7. Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.
Heyland DK; Gafni A; Levine MA
J Clin Epidemiol; 2000 Sep; 53(9):888-94. PubMed ID: 11004415
[TBL] [Abstract][Full Text] [Related]
8. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
Chesebro JH; Knatterud G; Roberts R; Borer J; Cohen LS; Dalen J; Dodge HT; Francis CK; Hillis D; Ludbrook P
Circulation; 1987 Jul; 76(1):142-54. PubMed ID: 3109764
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
Smith BJ
J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy guided by a decision analysis model: are there potential benefits for patient management?
Kellett J; Ryan B
Clin Cardiol; 1998 Feb; 21(2):93-8. PubMed ID: 9491947
[TBL] [Abstract][Full Text] [Related]
12. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
Kalish SC; Gurwitz JH; Krumholz HM; Avorn J
J Gen Intern Med; 1995 Jun; 10(6):321-30. PubMed ID: 7562123
[TBL] [Abstract][Full Text] [Related]
13. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
Grines CL; Nissen SE; Booth DC; Gurley JC; Chelliah N; Wolf R; Blankenship J; Branco MC; Bennett K; DeMaria AN
Circulation; 1991 Aug; 84(2):540-9. PubMed ID: 1907228
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
McLeod DC; Coln WG; Thayer CF; Perfetto EM; Hartzema AG
Ann Pharmacother; 1993; 27(7-8):956-62. PubMed ID: 8364282
[TBL] [Abstract][Full Text] [Related]
18. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
19. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
[TBL] [Abstract][Full Text] [Related]
20. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
